Services activity in the US is expanding while manufacturing momentum eases, which points to an economy still growing but in an uneven way. That kind of mixed backdrop often rewards companies that can grow earnings even when some sectors slow. The Healthy High Growth Potential screener focuses on exactly that type of stock. This article highlights three stocks from the screener that analysts expect to deliver strong earnings growth.
The stocks covered below are just a small sample from this idea. The full screen surfaced 132 more companies with similarly compelling stories that are not included here. To go deeper, head straight into the Healthy high growth potential screener to identify, analyze, and focus on the highest conviction opportunities that fit your own criteria.
Overview: Saatvik Green Energy manufactures and sells solar photovoltaic modules, with a focus on monocrystalline PERC and N TopCon panels used in residential, commercial, and utility scale solar projects. It also offers related EPC, installation, solar pump, and maintenance services in India and abroad.
Operations: Saatvik Green Energy generates its revenue primarily from manufacturing solar photovoltaic modules, with this segment contributing about ₹41,437 million.
Market Cap: ₹53.3b
Investors looking at the Healthy high growth potential theme may find Saatvik Green Energy interesting because its core business is directly tied to solar module demand. The company has a sizeable order book for solar PV modules that could support this, although the most recent quarter showed a sharp decline in sales and profit, which raises questions about how smooth the company’s trajectory will be. Margins have compressed, debt is not well covered by cash flow, and governance quality is still being tested, so investors need to weigh positive growth expectations against these financial and execution risks.
Saatvik Green Energy is tied to booming solar demand, yet recent margin pressure and governance questions hint at a more complex story. Get the full context in the 2 key rewards and 2 important warning signs (1 is major!)
Saatvik Green Energy and the two other stocks in this article all came from a single screener, but the real edge is in tailoring the filters to what matters most to you. Use our flexible Screener to mix growth, valuation, balance sheet and risk filters that match your style, or start with any of our ready made Investing Ideas.
Overview: Shaily Engineering Plastics designs and manufactures precision injection moulded components, with a strong focus on contract development and manufacturing of drug delivery devices such as inhalers, auto injectors, insulin pens and pharmaceutical packaging. The company also supplies consumer, furniture, lighting, appliance, automotive and personal care products in India and to around 40 export markets.
Operations: Shaily Engineering Plastics generates its revenue primarily from customised components of plastic and other materials, contributing about ₹10,246 million.
Market Cap: ₹152.8b
Shaily Engineering Plastics may be of interest to investors who want exposure to earnings that are closely linked to pharmaceutical outsourcing and high value exports. Its healthcare focused CDMO business for drug delivery devices is an important area for analysts assessing potential earnings and margin performance, supported by recent quarter results that show higher revenue and net income. At the same time, the stock carries a relatively high P/E and a funding mix that leans on borrowing, so any disappointment in GLP 1 pen uptake, regulatory approvals or global demand could have a significant impact on returns. Investors who understand that balance of growth potential and execution risk may find plenty more to unpack here.
Shaily Engineering Plastics is linking its high-value drug delivery exposure to a richer P/E that many investors may be only partially pricing in. Get the full story in the analyst forecasts for Shaily Engineering Plastics
Overview: Cemindia Projects is a Mumbai based construction and civil engineering contractor that builds large marine structures such as jetties, berths and dry docks, as well as tunnels, metros, airports, highways and industrial plants across India. Its strongest link to the Healthy high growth potential theme comes from specialist marine and underground projects where complex engineering work can support higher quality earnings, while the rest of its construction portfolio provides additional but more diversified revenue streams.
Operations: Cemindia Projects generates virtually all of its revenue from its construction segment, which contributed about ₹102,051 million, largely from projects in India.
Market Cap: ₹219.0b
Cemindia Projects may be worth a closer look if you want exposure to earnings supported by a large order book in marine and heavy civil projects like ports, metros and tunnels. Recent quarterly numbers show higher revenue and net income, while a shift toward technically demanding work and better working capital discipline may support margins and cash flow. On the other hand, concentrated exposure to complex projects and a sizeable share of work linked to its parent introduce execution and customer risk that could pressure profits if jobs are delayed or mispriced. The key question is whether Cemindia’s specialist engineering strengths can keep converting that pipeline into the earnings profile analysts are expecting.
Cemindia Projects could have earnings that are increasingly tied to complex marine and underground work, yet many investors may still be treating it like a generic contractor. See how the analysis report for Cemindia Projects reframes that story and what risk sits just beneath the surface
Some stocks move before the story is widely known. Catch potential breakouts and steady compounders while the data is still fresh and under the radar. Consider acting while information is still developing.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com